Validation of a 2-Gene Blood Test for Kawasaki Disease in Febrile Children - Takeaways - MDSpire

Validation of a 2-Gene Blood Test for Kawasaki Disease in Febrile Children

  • By

  • Ho-Chang Kuo

  • Xing Xue

  • Fang Liu

  • Richard D. Mortensen

  • C. James Chou

  • Bo Jin

  • Juan Wei

  • Qiong Luo

  • Ken-Pen Weng

  • Mindy Ming-Huey Guo

  • Kuender D. Yang

  • Kuo-Jung Su

  • Shih-Ting Kang

  • Sun Kim

  • Weiwei Li

  • James Schilling

  • Zhi Han

  • Naoto Ozawa

  • Takumi Ichikawa

  • Henry Chubb

  • Scott R. Ceresnak

  • Gary L. Darmstadt

  • Doff McElhinney

  • Harvey J. Cohen

  • Xuefeng B. Ling

  • May 28, 2026

  • 0 min

Share

  • 1

    Kawasaki disease (KD) is a significant cause of acquired heart disease in children, necessitating timely diagnosis and treatment.

  • 2

    A two-gene blood test measuring IFI27 and MCEMP1 was evaluated for its diagnostic accuracy in distinguishing KD from other febrile illnesses.

  • 3

    The study enrolled 541 children, with 243 diagnosed with KD, and assessed the test's performance under blinded conditions across multiple centers.

  • 4

    The assay demonstrated high sensitivity and specificity, with a dual-threshold model optimizing clinical decision-making for KD diagnosis.

  • 5

    The study adhered to rigorous standards for diagnostic accuracy, ensuring independent adjudication and minimizing bias in the evaluation process.

Original Source(s)

Related Content